2023 annual financial data
Redhill Biopharma 2023 Operating margin
Redhill Biopharma 2023 operating margin with verified reported values.
Direct answer
Operating margin was 193.45%.
Operating income was 12,632,000 USD and net income was 23,916,000 USD.
Operating cash flow was -35,820,000 USD.
Get free Redhill Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,530,000 USD
- Operating income
- 12,632,000 USD
- Net income
- 23,916,000 USD
- Operating cash flow
- -35,820,000 USD